BASF India (BASF) Q4 99/00 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 99/00 earnings summary
18 Oct, 2026Executive summary
FY ended 31 Mar 2000: income rose 11% YoY to Rs. 3,838.85 million; PBT increased 54% to Rs. 334.33 million, supported by higher capacity utilisation and lower interest costs.
PAT rose 11% to Rs. 199.84 million; higher tax expense, as investment-related tax relief at Mangalore declined, limited the increase.
Financial highlights
Sales were Rs. 3,796.55 million vs Rs. 3,418.04 million in FY99; other income was Rs. 42.30 million vs Rs. 37.77 million.
PBT was Rs. 334.34 million vs Rs. 216.68 million; PAT was Rs. 199.84 million vs Rs. 180.18 million.
Profit before interest, depreciation and tax was Rs. 675.03 million vs Rs. 588.83 million; depreciation was Rs. 215.34 million and interest Rs. 125.36 million.
Export sales of own-manufactured products increased to Rs. 344 million from Rs. 288 million; exports on an FOB basis were Rs. 340.69 million vs Rs. 285.74 million.
EPS was Rs. 8.27; a 40% interim dividend totaling Rs. 96.61 million was paid, with no final dividend recommended.
Outlook and guidance
Capacity augmentation steps began at the Thane and Mangalore factories; debottlenecking was also planned for expandable polystyrene capacity.
Dispersions exports rose from Rs. 7 million to Rs. 36 million, with the upward trend expected to continue in FY01.
R&D priorities include crop protection research and new product and process development across leather, paper, crop protection, textile chemicals and dye intermediates.
Latest events from BASF India
- PBT rose 20% as stronger products offset drought-hit agriculture.BASF
Q4 02/03 - Higher income and segment momentum were offset by rising depreciation and interest.BASF
Q4 96/97 - Lower interest and export gains lifted FY98 results, despite pressure on plastics.BASF
Q4 97/98 - Income rose 16% as diversified chemical businesses advanced amid uneven demand.BASF
Q4 98/99 - Sales and PAT grew despite margin pressure as portfolio changes set up the next phase of growth.BASF
Q4 00/01 - Sales rose 39%, PAT 26%; merger synergies offset pressure in several markets.BASF
Q4 01/02 - Sales and PBT rose 11% as debt fell and a 60% dividend was recommended.BASF
Q4 03/04 - Sales grew 13% as lower interest and stronger segment results lifted PBT 17%.BASF
Q4 04/05 - Earnings rose as interest costs and borrowings fell, despite uneven segment and market pressures.BASF
Q4 05/06